Frontlight ResearchEarly access
Head and neck cancer trials in United States
391 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peoplePhase II Randomized Study of Hypofractionated Versus Conventional Radiotherapy
- Where
- Dallas
- Age
- 18 years and over
- People
- 67
- Run by
- University of Texas Southwestern Medical Center
See details and how to joinNCT06080503 - Phase 4Taking peopleDPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment
- Where
- Belleville, Elizabeth, Hamilton, Jersey City, Livingston, Newark, New Brunswick, Somerville, Toms River
- Age
- 18 years and over
- People
- 100
- Run by
- Rutgers, The State University of New Jersey
See details and how to joinNCT07158164 - Phase 2Taking peopleSelective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
- Where
- Baltimore, Bel Air, Columbia, Glen Burnie
- Age
- 18 years and over
- People
- 61
- Run by
- University of Maryland, Baltimore
See details and how to joinNCT06088381 - Phase 1/2Taking peopleA Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
- Where
- Ann Arbor, Aurora, Baltimore, Cincinnati, Evanston, Grand Rapids, Houston, Indianapolis, Los Angeles, Milwaukee, New Haven, Newport Beach, New York, Providence
- Age
- 18 years and over
- People
- 200
- Run by
- Volastra Therapeutics, Inc.
See details and how to joinNCT05902988 - No phaseTaking peopleTissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- Where
- Nashville
- Age
- 18 years and over
- People
- 8,000
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT00898638 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - Phase 2Taking peopleA Phase II Study of ACR-368 and Low Dose Gemcitabine in R/M HNSCC
- Where
- Tampa
- Age
- 18 years and over
- People
- 43
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06597565 - Phase 3Taking peopleA Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
- Where
- Duarte, Houston, Lexington, Miami, Philadelphia, Providence, Sioux Falls, Tampa
- Age
- 18 years and over
- People
- 412 worldwide
- Run by
- Rakuten Medical, Inc.
See details and how to joinNCT06699212 · EU 2025-523017-28-00 - Phase 1/2Taking peopleA Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Where
- Boston, Dallas, Fairfax, Gilbert, Pittsburgh
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- ImmVira Pharma Co. Ltd
See details and how to joinNCT04370587 - Phase 4Taking peopleApixaban or Enoxaparin After Head and Neck Cancer Surgery
- Where
- Syracuse
- Age
- 18 years to 89 years
- People
- 76
- Run by
- Kiranya Arnold
See details and how to joinNCT07189897 - Phase 1Taking peopleEvaluating the Use of Dual Imaging Techniques for Detection of Disease in Patients With Head and Neck Cancer
- Where
- Nashville
- Age
- 19 years and over
- People
- 40
- Run by
- Vanderbilt-Ingram Cancer Center
See details and how to joinNCT05945875 - Phase 1/2Taking peopleA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Where
- Ann Arbor, Boston, Dallas, Houston, Los Angeles, Nashville
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT05941507 - Phase 1/2Taking peopleStudy of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 16
- Run by
- Coordination Pharmaceuticals, Inc.
See details and how to joinNCT05838729 - No phaseTaking peopleStudy of Non-invasive Acupuncture-like Transcutaneous Electrical Nerve Stimulation (Altens) to Help Alleviate Xerostomia After Radiation Therapy for Cancers of the Head and Neck
- Where
- Rochester
- Age
- 18 years and over
- People
- 75
- Run by
- University of Rochester
See details and how to joinNCT04805528 - Phase 1Taking peopleA Study of NX-1607 in Adults With Advanced Malignancies
- Where
- Aurora, Chapel Hill, Charlottesville, Chicago, Duarte, Houston, Los Angeles, Oklahoma City, San Francisco, Seattle
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05107674 - Phase 1/2Taking peopleA Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
- Where
- Columbus, Gilbert, Jacksonville, La Jolla, Los Angeles, New York, Rochester, Seattle, St Louis, Tampa
- Age
- 18 years and over
- People
- 240
- Run by
- A2 Biotherapeutics Inc.
See details and how to joinNCT06682793 - Early phase 1Taking peopleA Phase 0 Multicenter Study of the Pharmacodynamic Effects of Intratumoral Microdose Administration of PBA-0111 in Patients With Solid Tumors
- Where
- Shreveport
- Age
- 18 years and over
- People
- 12
- Run by
- Pure Biologics S.A.
See details and how to joinNCT06700070 - Early phase 1Not yet taking people in United States[Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
- Where
- Cleveland
- Age
- 18 years and over
- People
- 12
- Run by
- Qiubai Li
See details and how to joinNCT07026981 - No phaseTaking peopleNLit and Outcomes in HNC Survivor-Caregiver Dyads
- Where
- Kansas City
- Age
- 18 years and over
- People
- 150
- Run by
- University of Kansas Medical Center
See details and how to joinNCT07021885 - No phaseTaking peopleSentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
- Where
- Indianapolis
- Age
- 18 years and over
- People
- 94
- Run by
- Indiana University
See details and how to joinNCT05108090 - Phase 1Taking peoplePersonalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer
- Where
- Chicago
- Age
- 18 years and over
- People
- 36
- Run by
- University of Chicago
See details and how to joinNCT06005324 - No phaseTaking peopleMeasurable Residual Disease Detection Using Tumor-Informed ctDNA Surveillance After Curative-Intent Treatment in HPV-Independent Squamous Cell Carcinoma of the Head and Neck
- Where
- Boston
- Age
- 18 years and over
- People
- 75
- Run by
- Massachusetts Eye and Ear Infirmary
See details and how to joinNCT06744296 - Phase 1/2Taking peopleRAPA-201 Therapy of Solid Tumors
- Where
- Hackensack
- Age
- 18 years and over
- People
- 37
- Run by
- Rapa Therapeutics LLC
See details and how to joinNCT05144698 - No phaseEnrolling by invitationEffects of Flavor Modification for Management of Radiation Induced Dysgeusia
- Where
- Tampa
- Age
- 18 years to 90 years
- People
- 30
- Run by
- University of South Florida
See details and how to joinNCT06311877 - No phaseTaking peopleEvaluation of Radiobiological Effects in Skin Toxicities Head and Neck Cancer Patients With PBS Proton Therapy
- Where
- Knoxville
- Age
- 18 years and over
- People
- 100
- Run by
- Covenant Health Cancer Center
See details and how to joinNCT06183268